Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 4;10(9):218.
doi: 10.3390/jimaging10090218.

Decoding Breast Cancer: Using Radiomics to Non-Invasively Unveil Molecular Subtypes Directly from Mammographic Images

Affiliations

Decoding Breast Cancer: Using Radiomics to Non-Invasively Unveil Molecular Subtypes Directly from Mammographic Images

Manon A G Bakker et al. J Imaging. .

Abstract

Breast cancer is the most commonly diagnosed cancer worldwide. The therapy used and its success depend highly on the histology of the tumor. This study aimed to explore the potential of predicting the molecular subtype of breast cancer using radiomic features extracted from screening digital mammography (DM) images. A retrospective study was performed using the OPTIMAM Mammography Image Database (OMI-DB). Four binary classification tasks were performed: luminal A vs. non-luminal A, luminal B vs. non-luminal B, TNBC vs. non-TNBC, and HER2 vs. non-HER2. Feature selection was carried out by Pearson correlation and LASSO. The support vector machine (SVM) and naive Bayes (NB) ML classifiers were used, and their performance was evaluated with the accuracy and the area under the receiver operating characteristic curve (AUC). A total of 186 patients were included in the study: 58 luminal A, 35 luminal B, 52 TNBC, and 41 HER2. The SVM classifier resulted in AUCs during testing of 0.855 for luminal A, 0.812 for luminal B, 0.789 for TNBC, and 0.755 for HER2, respectively. The NB classifier showed AUCs during testing of 0.714 for luminal A, 0.746 for luminal B, 0.593 for TNBC, and 0.714 for HER2. The SVM classifier outperformed NB with statistical significance for luminal A (p = 0.0268) and TNBC (p = 0.0073). Our study showed the potential of radiomics for non-invasive breast cancer subtype classification.

Keywords: breast cancer; machine learning; mammography; molecular subtypes; naive Bayes; radiomics; support vector machine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The in- and exclusion criteria flowchart used during this study.
Figure 2
Figure 2
The tumor segmentation process. Starting with normalization of the original DM image, where breast lesions (red) classified as ‘calcification’ underwent image enhancement. Breast lesions classified as ‘mass’ underwent segmentation using a region-growing algorithm. The segmentations were finalized with the use of the image segmenter tool from MATLAB to obtain the final tumor segmentation.
Figure 3
Figure 3
An example of image enhancement for a calcification region where (a) is the original DM image and (b) is the enhanced image, making the calcification more pronounced.
Figure 4
Figure 4
Examples of breast tumor segmentations for (a) luminal A, (b) luminal B, (c) TNBC, and (d) HER2.
Figure 5
Figure 5
The selected radiomic features for (a) luminal A vs. non-luminal A, (b) luminal B vs. non-luminal B, (c) TNBC vs. non-TNBC, and (d) HER2 vs. non-HER2 classification tasks.
Figure 6
Figure 6
The ROC curves of the SVM (blue) and NB (yellow) classifiers for (a) luminal A vs. non-luminal A, (b) luminal B vs. non-luminal B, (c) TNBC vs. non-TNBC, and (d) HER2 vs. non-HER2.

References

    1. Siegel R.L., Giaquinto A.N., Jemal A. Cancer statistics, 2024. CA A Cancer J. Clin. 2024;74:12–49. doi: 10.3322/caac.21820. - DOI - PubMed
    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. WHO . A Short Guide to Cancer Screening: Increase Effectiveness, Maximize Benefits and Minimize Harm. World Health Organization, Regional Office for Europe; Geneva, Switzerland: 2022. pp. 1–45.
    1. Harbeck N., Penault-Llorca F., Cortés J., Gnant M., Houssami N., Poortmans P., Ruddy K., Tsang J., Cardoso F. Breast cancer. Nat. Rev. Dis. Primers. 2019;5:66. doi: 10.1038/s41572-019-0111-2. - DOI - PubMed
    1. Orrantia-Borunda E., Anchondo-Nuñez P., Acuña-Aguilar L.E., Gómez-Valles F.O., Ramírez-Valdespino C.A. Breast Cancer. National Library of Medicine; Bethesda, ML, USA: 2022. Subtypes of Breast Cancer; pp. 31–42. - DOI - PubMed

LinkOut - more resources